Washington DC, Jan. 13 -- The Korea Advanced Institute of Science and Technology (KAIST) researchers have developed a way to reprogram immune cells already inside tumours into cancer-killing machines.

A drug injected directly into the tumour is absorbed by macrophages, prompting them to recognise and attack cancer cells while activating nearby immune defences.

This eliminates the need for lab-based cell extraction and modification. In animal models, the strategy significantly slowed tumour growth and sparked strong anticancer immune responses.

KAIST (President Kwang Hyung Lee) announced that a research team led by Professor Ji-Ho Park from the Department of Bio and Brain Engineering has developed a new treatment approach.

When a drug ...